MESO
Mesoblast Limited American Depositary Shares (MESO)
$
30About Mesoblast Limited American Depositary Shares (MESO)
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Details
Daily high
$17.65
Daily low
$15.92
Price at open
$15.92
52 Week High
$22.00
52 Week Low
$1.72
Market cap
2.0B
Dividend yield
0.00%
Volume
535,023
Avg. volume
600,071
P/E ratio
-19.45
Mesoblast Limited American Depositary Shares News
Details
Daily high
$17.65
Daily low
$15.92
Price at open
$15.92
52 Week High
$22.00
52 Week Low
$1.72
Market cap
2.0B
Dividend yield
0.00%
Volume
535,023
Avg. volume
600,071
P/E ratio
-19.45